These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 28454436)
1. SATB1 promotes epithelial-mesenchymal transition and metastasis in prostate cancer. Qi H; Fu X; Li Y; Pang X; Chen S; Zhu X; Li F; Tan W Oncol Lett; 2017 Apr; 13(4):2577-2582. PubMed ID: 28454436 [TBL] [Abstract][Full Text] [Related]
2. SATB1 overexpression regulates the development and progression in bladder cancer through EMT. Wan F; Cheng C; Wang Z; Xiao X; Zeng H; Xing S; Chen X; Wang J; Li S; Zhang Y; Xiang W; Zhu Z; Johnson C; Zhu Z PLoS One; 2015; 10(2):e0117518. PubMed ID: 25706386 [TBL] [Abstract][Full Text] [Related]
3. SOX4 induces tumor invasion by targeting EMT-related pathway in prostate cancer. Liu Y; Zeng S; Jiang X; Lai D; Su Z Tumour Biol; 2017 May; 39(5):1010428317694539. PubMed ID: 28466783 [TBL] [Abstract][Full Text] [Related]
4. SATB1 promotes prostate cancer metastasis by the regulation of epithelial-mesenchymal transition. Mao LJ; Yang CH; Fan L; Gao P; Yang DR; Xue BX; Zheng JN; Shan YX Biomed Pharmacother; 2016 Apr; 79():1-8. PubMed ID: 27044805 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer. Tu W; Luo M; Wang Z; Yan W; Xia Y; Deng H; He J; Han P; Tian D Liver Int; 2012 Aug; 32(7):1064-78. PubMed ID: 22583549 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition. Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880 [TBL] [Abstract][Full Text] [Related]
7. AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling. Wang B; Gu Y; Hui K; Huang J; Xu S; Wu S; Li L; Fan J; Wang X; Hsieh JT; He D; Wu K Urol Oncol; 2018 Oct; 36(10):472.e11-472.e20. PubMed ID: 30139661 [TBL] [Abstract][Full Text] [Related]
8. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851 [TBL] [Abstract][Full Text] [Related]
9. CD147 promotes epithelial-mesenchymal transition of prostate cancer cells via the Wnt/β-catenin pathway. Fang F; Li Q; Wu M; Nie C; Xu H; Wang L Exp Ther Med; 2020 Oct; 20(4):3154-3160. PubMed ID: 32855684 [TBL] [Abstract][Full Text] [Related]
10. SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation. Chen Z; Li Z; Li W; Zong Y; Zhu Y; Miao Y; Xu Z Dig Dis Sci; 2015 Nov; 60(11):3304-17. PubMed ID: 26108419 [TBL] [Abstract][Full Text] [Related]
11. Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer. Yamamichi F; Shigemura K; Behnsawy HM; Meligy FY; Huang WC; Li X; Yamanaka K; Hanioka K; Miyake H; Tanaka K; Kawabata M; Shirakawa T; Fujisawa M Scand J Urol; 2014 Dec; 48(6):523-32. PubMed ID: 25356787 [TBL] [Abstract][Full Text] [Related]
12. SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma. Zhao Z; Ma J; Wu K; Chen L; Yu J; Hu W; Zhang K Clin Transl Oncol; 2016 Sep; 18(9):878-83. PubMed ID: 26563145 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4. Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117 [TBL] [Abstract][Full Text] [Related]
14. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis. Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131 [TBL] [Abstract][Full Text] [Related]
15. Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer. Wang C; Wang L; Su B; Lu N; Song J; Yang X; Fu W; Tan W; Han B Prostate; 2014 May; 74(7):689-701. PubMed ID: 24619958 [TBL] [Abstract][Full Text] [Related]
16. ZNF24 is upregulated in prostate cancer and facilitates the epithelial-to-mesenchymal transition through the regulation of Twist1. Huang X; Liu N; Xiong X Oncol Lett; 2020 May; 19(5):3593-3601. PubMed ID: 32269634 [TBL] [Abstract][Full Text] [Related]
17. ITGBL1 promotes EMT, invasion and migration by activating NF-κB signaling pathway in prostate cancer. Li W; Li S; Yang J; Cui C; Yu M; Zhang Y Onco Targets Ther; 2019; 12():3753-3763. PubMed ID: 31190876 [No Abstract] [Full Text] [Related]
18. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling. Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition. Song R; Zhang J; Huang J; Hai T Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220 [TBL] [Abstract][Full Text] [Related]